We are open for all your health care needs. Visitor restrictions still apply.
The Department of Addiction Medicine at St. Elizabeth's Medical Center is currently a very active division of Internal Medicine providing comprehensive and multi-dimensional care for individuals with Substance Use Disorder (SUD), particularly opioids, alcohol and benzodiazepines.
736 Cambridge St.
Brighton, MA 02135
617-789-2574
St. Elizabeth's Comprehensive Addiction Program (SECAP), founded in 1976, is Boston’s oldest hospital-based program and the only Level 4 certified, medically monitored inpatient detoxification program in Massachusetts. Annually we provide care for over 1,000 patients.
The program’s capacity is 14 beds on any given day. Patients are admitted in a hospital environment, which means around the clock monitoring by nursing staff and daily physician visit. Patients have access to all hospital’s services such as radiology, lab, physical therapy, psychiatric consultations, and subspecialty consult services, which allows us to provide care for patients with underlying medical conditions. This is the unique aspect of our program that by BSAS definition places us at a level IV category.
We provide care for a wide variety of addictions. Our treatment protocols for opioids, alcohol and benzodiazepine dependence are evidence-based and symptom triggered, and are tailored per individual needs. Our team successfully detoxes patients from opiates, alcohol, and benzodiazepine by using buprenorphine-naloxone (Suboxone), chlordiazepoxide (Librium), and oxazepam (Serax).
There is no FDA approved medication for cocaine or other stimulant withdrawals, therefore we do not offer a universal protocol, but patients with cocaine use disorder can also be treated here by receiving medications commonly known as comfort meds.
Our team also offers a comfortable path for patients who are interested in tapering off buprenorphine-naloxone (Suboxone), Ultram, and other substances resulting in dependence on individual bases.
The length of stay depends on the drug of choice and individual’s need, but on average is 3.5-4 days for opiates and alcohol and 7 days for benzodiazepines.
During the course of hospitalization, patients will meet with detox counselors on daily basis. Counselors engage patients in group therapies, meditation, individual counseling, and discharge planning. Family meetings are also facilitated by our detox counselors per patient's or family’s request.
Mutual help groups (Friends of SECAP, AA) provide on-site support to aid in the transition to outpatient care.
To contact the SECAP Detox program, call 617-789-2574.
Unit Coordinators: Tina Robinson, Anna Roberto
SECAP’s on-call physician is available to provide consultation services to all St. Elizabeth's Medical Center's patients with substance use disorder who are admitted for medical, surgical, maternity or psychiatric conditions.
To access the consult service, use the Page-me system to contact the on-call physician.
St. Elizabeth's Medical Center's outpatient addiction treatment programs offer medication assisted treatment (MAT), intensive outpatient programs (IOP), group therapy sessions and individual counseling for patients with substance use disorder. The admission to our outpatient program is open to the general public. The cost is covered by most insurance companies, but we recommend checking with your specific provider. Some insurers may require a referral from the patient's primary care provider.
Researches show that MAT is the Gold Standard to treat Substance use disorder and significantly reduce the mortality and morbidity caused by addiction. At our Outpatient Addiction Treatment program, an Addiction Specialist (a physician who is board certified or board eligible in Addiction Medicine) offers the patients a variety of treatments for their disease and connects them to other resources that are also available through our program.
At the St. Elizabeth's Addiction Treatment Program MAT clinic, we offer buprenorphine/naloxone (Suboxone), oral and injectable naltrexone (Vivitrol), disulfiram (Antabuse), and acamprosate (Campral). We will be offering sublocade (injectable Suboxone) in near future.
We do not offer methadone but we can help to connect patients who are interested in pursuing methadone treatment to our sister program at Brighton Marine.
To contact the Addiction Treatment Program MAT program at St. Elizabeth's, call 617-562-5378.
Unit Coordinator: Rosano Oliveira
The key to a successful recovery is engaging in both medical and counseling services. The combination of medication-assisted treatment and behavioral health provides a strong foundation for recovery.
The Outpatient Psycho-Social service at SECAP, licensed by the Department of Public Health, offers outpatient services geared toward all demographic groups except for pediatrics. Our outpatient services consist of tailored programs at various levels of intensity to meet individual needs.
Following day or evening treatment, most individuals seek the structure and support of an ongoing group. In addition to one-on-one counseling, SECAP offers group support, including:
To contact SECAP's psycho-social programs, call 617-789-2916.
Detox Counselors: Susan Mariano and Ala Shield
The Department of Addiction Medicine at St. Elizabeth's Medical Center collaborates closely with other departments within the hospital.
Many patients with Substance Use Disorder suffer from other comorbidities such as infectious diseases (HIV, Hepatitis B, Hepatitis C), psychiatric disorders (anxiety, depression, bipolar mood disorder, post-traumatic stress disorder, schizophrenia), cardiac and pulmonary diseases as a result of smoking (COPD, coronary artery disease, hypertension). A patient may be pregnant.
We can help our patients access the other subspecialties offered at St. Elizabeth's Medical Center, including:
title=" About Addiction" fontawesome="fa-hospital-o" class="col-xs-12" color="red"
Over 2.6 million people in the U.S. suffer from opioid use disorder according to the Substance Abuse and Mental Health Services Administration. Since 2001, the number of people who have fatally overdosed on prescription opioids has more than tripled, and the number of people who have died from opioid overdoses has increased more than 600 percent.
Alcohol Use Disorder (AUD) in the United States is even more prevalent. According to the 2018 NSDUH, 14.4 million adults ages 18 and older (5.8 percent of this age group) had AUD. This includes 9.2 million men (7.6 percent of men in this age group) and 5.3 million women (4.1 percent of women in this age group).
Only about 7.9 percent of adults who had AUD in the past year received treatment. This includes 8.0 percent of males and 7.7 percent of females with AUD in this age group.
According to the same data, an estimated 401,000 adolescents ages 12–17 (1.6 percent of this age group) had AUD. This number includes 173,000 males (1.4 percent of males in this age group) and 227,000 females (1.9 percent of females in this age group). About 5.0 percent of youth who had AUD in the past year received treatment. This includes 5.6 percent of males and 4.6 percent of females with AUD in this age group.
Addiction Medicine
Internal Medicine,
Addiction Medicine
Internal Medicine